Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 14, 2017

Total Value ($000): $363,082 (100.0% shares, 0.0% debt)

Holdings (11)

— ARIAD PHARMACEUTICALS INC 44.0%

Value ($000) $159,853 Shares 12,850,000 Est. Cost $6.73 Unrealized —

BIIB BIOGEN INC 24.2%

Value ($000) $87,909 Shares 310,000 Est. Cost $287.35 Unrealized +3.2%

— MEDICINES CO 16.4%

Value ($000) $59,462 Shares 1,752,000 Est. Cost $29.63 Unrealized —

INVA INNOVIVA INC 8.8%

Value ($000) $31,832 Shares 2,975,000 Est. Cost $10.89 Unrealized -3.6%

— NOVELION THERAPEUTICS INC 2.4%

Value ($000) $8,630 Shares 1,025,000 Est. Cost $8.42 Unrealized —

— INTRA CELLULAR THERAPIES INC 1.5%

Value ($000) $5,432 Shares 360,000 Est. Cost $27.96 Unrealized —

— ADVAXIS INC 1.0%

Value ($000) $3,579 Shares 500,000 Est. Cost $8.09 Unrealized —

— VIVUS INC 0.8%

Value ($000) $2,960 Shares 2,573,943 Est. Cost $9.08 Unrealized —

— APRICUS BIOSCIENCES INC 0.5%

Value ($000) $1,882 Shares 1,447,906 Est. Cost $1.30 Unrealized —

— AVEO PHARMACEUTICALS INC 0.3%

Value ($000) $917 Shares 1,700,000 Est. Cost $1.84 Unrealized —

ABBV ABBVIE INC. 0.2%

Value ($000) $626 Shares 10,000 Est. Cost $38.85 Unrealized +7.6%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ARIAD PHARMACEUTICALS INC	12,850,000	$159,853	44.0%	$6.73	—	COM	04033A100
BIIB	BIOGEN INC	310,000	$87,909	24.2%	$287.35	+3.2%	COM	09062X103
—	MEDICINES CO	1,752,000	$59,462	16.4%	$29.63	—	COM	584688105
INVA	INNOVIVA INC	2,975,000	$31,832	8.8%	$10.89	-3.6%	COM	45781M101
—	NOVELION THERAPEUTICS INC	1,025,000	$8,630	2.4%	$8.42	—	COM NEW	67001K202
—	INTRA CELLULAR THERAPIES INC	360,000	$5,432	1.5%	$27.96	—	COM	46116X101
—	ADVAXIS INC	500,000	$3,579	1.0%	$8.09	—	COM NEW	007624208
—	VIVUS INC	2,573,943	$2,960	0.8%	$9.08	—	COM	928551100
—	APRICUS BIOSCIENCES INC	1,447,906	$1,882	0.5%	$1.30	—	COM NEW	03832V307
—	AVEO PHARMACEUTICALS INC	1,700,000	$917	0.3%	$1.84	—	COM	053588109
ABBV	ABBVIE INC.	10,000	$626	0.2%	$38.85	+7.6%	COM	00287Y109